NK cells are an important component of innate immunity, capable of mediating cytotoxicity against tumor and virus-infected cells. Eff ector functions of NK cells are regulated by the coordinated interaction of activating and inhibitory receptors ( 1 ) . Determining precise signaling events downstream of these receptors is paramount for successful clinical utilization of NK cells. One of the activating receptors, NKG2D, is a lectin type II transmembrane protein expressed on all human and mouse NK cells, and it recognizes MIC-A/B ( 2 ) and ULBP-1/2/3 (in humans) ( 3 ) , and H60 ( 4, 5 ), Rae-1 ␣ / ␤ / ␥ / ␦ / ( 5 ), and Mult-1 (in mice) ( 6 ) . Upon activation, NKG2D employs Src family protein tyrosine kinases (PTKs) to initiate two distinct signaling pathways ( 7 -11 ) , leading to eff ector functions. In the fi rst pathway, activated PTK phosphorylates Tyr-Ile-Asn-Met (YINM) motif-bearing DAP10, which in turn recruits phosphatidylinositol 3-kinase (PI3K) ( 9 ) . In the second pathway, PTK phosphorylates the immunoreceptor tyrosine-based activation motif (ITAM) -containing KARAP/DAP12, which subsequently triggers Syk and ZAP70 ( 8 -11 ) . Another major activating receptor, Ly49D, which associates with both DAP10 and DAP12 ( 12, 13 ) , is also a mouse lectin type II transmembrane protein, which interacts with classical MHC class I, H2-D d ( 14 ) .
Natural cytotoxicity receptors (NCRs) are immunoglobulin-like transmembrane glycoproteins that recognize unknown ligands on several tumor cells. The NCR family contains three human (NKp46/NCR1, NKp44/NCR2, and NKp30/NCR3) and one mouse (NKp46/ NCR1) members ( 15 -18 ) . NKp46 and NKp30 associate with ITAM-bearing CD3 ( 17 ) and FCR ␥ ( 19 ), respectively, whereas NKp44 recruits DAP12 ( 20 ) . Although cellular ligands for NCRs have not been found, NCR1 is known to interact with hemagglutinin (HA) of infl uenza and HA-neuraminidase of Sendai virus ( 21 ) . NK1.1 (Nkrp1c) is a unique cell marker expressed on NK and NKT cells ( 22 ) . Although the activating ligands for Nkrp1c have yet to be determined, the inhibitory ligands for its related family members Nkrp1d and Nkrp1f have been defi ned as the Clr family of C-type lectins ( 23 ) . NK1.1 physically associates with FcR ␥ to mediate its signal ( 24 ) . Several NK inhibitory receptors have been identifi ed, such as KIR, Ly49A, Ly49C, Ly49G2, and Ly49I ( 25 ) . These inhibitory receptors recognize classical MHC class I molecules. Upon interaction, they recruit phosphatases to the immunoreceptor tyrosine-based inhibitory motif in the cytoplasmic domains ( 26 ) . Thus, NK cells use a complex set of receptors and signaling pathways to achieve their intended eff ector functions. Despite recent studies ( 8 -13 ) that have provided deeper insights regarding the activation pathways, multiple knowledge gaps exist, hindering comprehensive clinical applications of NK cells.
Class I PI3Ks generate secondary lipid messengers that regulate a wide array of intracellular signaling pathways in numerous cell types ( 27 ) . Several isoforms of regulatory p85 (p85 ␣ , p55 ␣ , p50 ␣ , p85 ␤ , and p55 ␥ ) and catalytic p110 (p110 ␣ , p110 ␤ , p110 ␥ , and p110 ␦ ) subunits have been described to play distinct functions ( 27 ) . For example, mice lacking the p85 ␣ regulatory or p110 ␦ catalytic subunit show severely impaired B and T cell development and functions ( 28, 29 ) . Deletion of individual catalytic or regulatory subunits results in altered expression of other subunits ( 30, 31 ) . Thus, use of gene KO mice precludes proper evaluation of the PI3K isoform-selective functions in lymphocytes. To avoid these inherent complications in using KO mice, we generated mice with a point mutation that completely inactivated the catalytic function of p110 ␦ subunit (further referred to as p110 ␦ D910A/D910A mice) ( 32 ) . This point mutation, Asp 910 → Ala (D910A), resulted in a complete loss-of-function locus but retained the normal expression levels of p110 ␦ protein. More importantly, this strategy did not result in any compensatory increase of p110 ␣ , p110 ␤ , and total p85 subunits in thymocytes ( 32 ) .
In this study, using the p110 ␦ D910A/D910A mice, we demonstrate that PI3K-p110 ␦ plays a pivotal role in the development and eff ector functions of NK cells. p110 ␦ D910A/D910A mice had reduced NK cellularity and a selective impairment in the maturation of Ly49C and Ly49I NK subsets. Further, mature NK cell populations, as defi ned by CD27 and CD11b, were markedly altered in p110 ␦ D910A/D910A mice. p110 ␦ inactivation marginally impaired NK cell -mediated cytotoxicity against tumor and virally infected cells. However, NKG2D, Ly49D, and NK1.1 receptor -mediated cytokine and chemokine generation were severely impaired in NK cells from p110 ␦ D910A/D910A mice. In addition, cytokine generation by p110 ␦ D910A/D910A NK cells in response to virally infected cells was markedly reduced. Biochemical analysis indicates that defects in the activation and phosphorylation of the c-Jun N-terminal kinase (JNK) pathway could be responsible for the impaired cytokine generation in p110 ␦ D910A/D910A NK cells. Our results demonstrate that the PI3K-p110 ␦ subunit plays a crucial role in NK cellularity, terminal maturation, and cytokine/chemokine generation.
other Ly49 receptors, and the adverse eff ect of p110 ␦ mutation only aff ected the maturation of Ly49C and Ly49I NK subsets.
Reduction in the absolute NK cell numbers and in Ly49C/I needs further explanation. PI3K-mediated signaling initiates key prosurvival pathways ( 36 ) . It is also important to note that only Ly49C/I receptors have the ability to recognize the self -MHC class I molecules, H2-K b and H2-D b . Expression of these MHCs are not altered because of the inactivation of p110 ␦ , arguing against one possible extrinsic eff ect during NK maturation (Fig. S3 , available at http://www.jem.org/ cgi/content/full/jem.20072327/DC1). Currently, we cannot exclude the potential possibility that p110 ␦ -mediated signaling is required for " licensing " ( 37 ) or " arming " ( 38 ) . In the absence of p110 ␦ , either the rate of NK cell proliferation or cell survival could have been altered. To diff erentiate between these two possibilities, spleen-derived IL-2 -activated NK cells were labeled with BrdU to analyze their proliferation. Results presented in Fig. 3 (a -c) demonstrate that the overall percentages of proliferating p110 ␦ D910A/D910A NK cells were significantly reduced. In particular, proliferation of Ly49C/I subsets were more severely impaired (P = 0.0096) than other Ly49 subsets. To determine the role of apoptosis in the reduction of Ly49C/I subsets, NK cells were cultured with IL-2 for 6 d, and individual subsets were analyzed with 7-aminoactinomycin D (7-AAD) and Annexin V staining. Our data indicate that analyzed for the expression of CD122, NKG2D, NKG2A, CD11b, CD244, CD43, CD49b, and CD51. Expression levels of CD122, NKG2D, NKG2A, CD11b, and CD244 were unaff ected in p110 ␦ D910A/D910A mice ( Fig. 1 d ) . Inactivation of p110 ␦ also did not aff ect the expression of CD49b, CD51, and CD43 in CD3 Ϫ NK1.1 + NK cells ( Fig. 1 d ) . Similar results were observed in IL-2 -activated NK cells (Fig. S2, a and b) .
p110 ␦ regulates the terminal maturation of Ly49C/I NK subsets Acquisition of distinct Ly49 receptors by CD3 Ϫ NK1.1 + NK cells is an important developmental step by which the NK " repertoire " is generated. Expression of Ly49C and Ly49I were severely impaired in the fresh NK cells from the BM and spleen of p110 ␦ D910A/D910A mice ( Fig. 2, a and b ) . However, expression of inhibitory Ly49A or Ly49G2 and activating Ly49D receptors was unaff ected by p110 ␦ inactivation in fresh NK cells ( Fig. 2, a and b ) . Analyses of IL-2 -activated BM NK cells further indicated the defective expression of Ly49C and Ly49I receptors ( Fig. 2 c ) . Similar to freshly isolated NK cells, the proportion of Ly49A, Ly49D, and Ly49G2 subsets remained unaff ected in IL-2 -activated BM NK cells ( Fig. 2 c ) . Comparable results were observed in spleen-derived and IL-2 -activated NK cells ( Fig. 2 d ) from p110 ␦ D910A/D910A mice. Thus, a reduction in Ly49C or Ly49I did not depend on the coexpression of cells and analyzed for CD27 and CD11b markers. Fig. 4 shows that a lack of functional p110 ␦ altered the ratio of CD27-and CD11b-expressing NK subsets. There was a signifi cant reduction in the CD27 High CD11b Low NK cells in both fresh BM ( Fig. 4 a ) and spleen ( Fig. 4 b ) of p110 ␦ D910A/D910A mice. The CD27 High CD11b High NK cell numbers were also aff ected in the spleen of p110 ␦ D910A/D910A mice. More importantly, the decrease in the CD27 High CD11b High population was correlated with a concomitant increase in the CD27 Low CD11b High NK subsets in both fresh BM and spleen of the p110 ␦ D910A/D910A NK population. Earlier studies have also indicated a skewed expression of Ly49C/I receptors in CD27 Low CD11b high NK cells ( 39 ) . Because we observed a specifi c reduction in the Ly49C/I subsets in the absence of functional p110 ␦ , we analyzed the fresh NK cells from p110 ␦ D910A/D910A mice for CD27 and Ly49 expressions. Results presented in Fig. 4 c indicate that Ly49A, Ly49I, Ly49D, and Ly49G2 NK subsets with CD27 High positivity were reduced more in p110 ␦ D910A/D910A NK cells than those of WT/WT. However, the reduction in the Ly49I + CD27 High NK subset was more severe compared with other subsets in p110 ␦ D910A/D910A NK cells. Based on these among NK cells from spleen ( Fig. 3 d ) , there was a consistent, signifi cant but minimal increase of Annexin V -positive Ly49 subsets from p110 ␦ D910A/D910A mice ( < 10% of the total analyzed). However, no major changes were seen between BMderived WT/WT and p110 ␦ D910A/D910A NK cells (Fig. S4) . These results indicate that a lack of p110 ␦ most probably aff ects the proliferative rate of NK cells and that the eff ect on their survival is minimal. cytotoxic potential of p110 ␦ D910A/D910A NK cells was marginally reduced ( Fig. 5 a ) . Similar to fresh NK cells, IL-2 -activated splenic p110 ␦ D910A/D910A NK cells also had a reduced ability to lyse EL4 H60 compared with WT/WT NK cells ( Fig.  5 b ) . As expected, there is only a minimal lysis of EL4 by either IL-2 -activated WT/WT or p110 ␦ D910A/D910A NK cells ( Fig. 5 b ) . This cytotoxicity response directed to EL4 H60 was primarily mediated through the NKG2D receptor, because an anti-NKG2D mAb (C7) abrogated this response in both WT/ WT and p110 ␦ D910A/D910A NK cells (Fig. S5 , available at http://www.jem.org/cgi/content/full/jem.20072327/DC1). Another tumor cell line, YAC-1, which naturally expresses H60, was also lysed less by p110 ␦ D910A/D910A NK cells ( Fig. 5 b ) .
CD27
results, we conclude that p110 ␦ is needed for both Ly49C/I subset specifi cation and proliferation, and CD27 High CD11b High NK maturation.
Cytotoxicity is marginally impaired in p110 ␦ D910A/D910A NK cells A detailed analysis of the role of PI3K and its subunits in regulating " induced-self " and " missing-self " recognition is lacking. Therefore, we evaluated the ability of p110 ␦ D910A/D910A NK cells to mediate cytotoxicity toward several tumor targets in 51 Cr-release assays. Fresh NK cells were purifi ed from splenocytes and were tested for their ability to mediate the lysis of EL4 H60 target cells ( 42, 43 ) . Compared with WT/WT, the sets are severely decreased and total numbers of spleen and BM cells are signifi cantly reduced in p110 ␦ D910A/D910A mice, sorting enough Ly49C/I single-positive NK subsets is diffi cult. Therefore, we pooled Ly49C/I single-positive and Ly49C/I, Ly49G2 double-positive NK subsets (Ly49C/I + Ly49G2 ± ) for the 51 Crrelease assay. Cytotoxicity of Ly49C/I + Ly49G2 ± NK subsets from p110 ␦ D910A/D910A mice ( Fig. 5 c ) was relatively more impaired compared with sorted Ly49C/I Ϫ Ly49G2 + ( Fig. 5 d ) and Ly49C/I Ϫ Ly49G2 Ϫ ( Fig. 5 e ) NK subsets. Nevertheless, these results for the fi rst time demonstrate a preferential requirement of p110 ␦ by Ly49C/I NK subsets for cytotoxicity.
Next, we evaluated the ability of p110 ␦ D910A/D910A mice to clear in vivo tumor growth. Toward this, WT/WT and p110 ␦ D910A/D910A mice were challenged with RMA and RMA/ S cells. These tumor cells were labeled with CFSE or SNAF and were injected in combinations into the intraperitoneal cavity; 6 h later, peritoneal exudates were collected and analyzed for the level of tumor clearance and NK cell accumulation.
Similar observations were made using BM-derived NK cells (unpublished data). Cells that lack or have reduced expression of self -MHC class I molecules are susceptible to NK-mediated cytotoxicity ( 44 ) . As seen in Fig. 5 b , p110 ␦ D910A/D910A NK cells showed reduced cytotoxicity against RMA/S cells, which express lower levels of MHC class I. To test whether p110 ␦ plays a role in Ly49D-mediated cytotoxicity, we used Chinese hamster ovary (CHO) cells that express a hamster homologue of H2-D d ( 14 ) . As shown in Fig. 5 b , spleen-derived, IL-2 -activated p110 ␦ D910A/D910A NK cells had reduced lysis against CHO cells.
Because the terminal maturation of Ly49C and Ly49I NK subsets was signifi cantly impaired in the p110 ␦ D910A/D910A mice, we intended to analyze their functional abilities to recognize and lyse tumor cells. Toward this, the IL-2 -activated splenic NK cells derived from p110 ␦ D910A/D910A mice were stained with anti-Ly49C/I and anti-Ly49G2 mAbs, sorted, and tested against EL4 H60 . Because proportions of Ly49C and Ly49I sub- protein (MIP) 1 ␣ , MIP-1 ␤ , and regulated upon activation, normal T cell expressed and secreted (RANTES) ( 46 ) . Therefore, we tested CD3 Ϫ NK1.1 + NK cells for cytokine generation. Freshly purifi ed CD3 Ϫ NK1.1 + NK cells from WT/WT spleens generated an optimal amount of cytokines and chemokines when activated by plate-bound anti-NKG2D, anti-Ly49D, and anti-NK1.1 mAbs. However, NK cells from p110 ␦ D910A/D910A mice were signifi cantly impaired in generating these cytokines and chemokines ( Fig. 6 a ) . Thus, the ex vivo -purified NK cells that use NKG2D -DAP10 complexes for signaling depend on p110 ␦ to generate cytokine response. Next, we tested the role of p110 ␦ in cytokine and chemokine generation by IL-2 -activated splenic NK cells. As seen in Fig. 6 b , WT/WT NK cells produced a large amount of IFN-␥ or GM-CSF when stimulated with anti-NKG2D, anti-Ly49D, and anti-NK1.1 mAbs. However, p110 ␦ D910A/D910A NK cells were severely impaired to produce these cytokines. Further, generation
Clearance of RMA/S versus RMA cells was calculated compared with the input ratio, which was normalized to one. RMA cells, which are not cleared by either WT/WT or p110 ␦ D910A/D910A mice, acted as an internal control. Our results show that both WT/WT and p110 ␦ D910A/D910A mice did not clear RMA cells. Compared with WT/WT, the ability of the p110 ␦ D910A/D910A mice to clear the RMA/S cells was marginally impaired (Fig. S6, a and (Fig. S6, c and d) . These results confi rm our in vitro observations and the earlier reports on these mice ( 45 ) .
Cytokine/chemokine generation is impaired in p110 ␦ D910A/D910A NK cells NK cells can generate infl ammatory cytokines and chemokines such as IFN-␥ , GM-CSF, macrophage infl ammatory 51 Cr-labeled target cells at the indicated effector/target (E/T) ratios. Cytotoxicity was tested against EL4, EL4 H60 , YAC-1, RMA/S, or CHO cells. Three to fi ve mice were used for each genotype. Open and closed circles represent the mean values from WT/WT and p110 ␦ D910A/D910A mice, respectively. NKG2D-mediated cytotoxic potential of the Ly49C/ I + NK subset was more severely impaired compared with Ly49C/I Ϫ NK subsets. (c) Ly49C/I + Ly49G2 ± , (d) Ly49C/I Ϫ Ly49G2 + , and (e) Ly49C/I Ϫ Ly49G2 Ϫ NK subsets were sorted from IL-2 -activated splenic NK cells derived from WT/WT and p110 ␦ D910A/D910A mice, rested for 12 h, and used in cytotoxicity assays with EL4 H60 as target cells. Data presented are means ± SD (a and b) or are representative (c -e) of at least three independent experiments. and we did not see any preferential reduction in Ly49C/I subsets. This indicates that although p110 ␦ regulates both of the effector functions, it is critically required for cytokine generation. To further investigate whether the defect is at the transcriptional level, we quantifi ed the amounts of IFN-␥ -encoding mRNA before and after plate-bound anti-NKG2D mAb activation. Fig. 8 a demonstrates a signifi cantly lower copy number of IFN-␥ -encoding mRNA in both BM-and spleen-derived p110 ␦ D910A/D910A NK cells, indicating a defect at the transcriptional level. To determine whether this is generalized hyporesponsiveness or an exclusive defect associated with YINM-and ITAM-containing activation receptors, we stimulated the NK cells with IL-12, IL-18, or both in the presence of a suboptimal concentration of anti-NKG2D mAb (A10). Interestingly, both WT/WT and p110 ␦ D910A/D910A -derived NK cells responded equally well to distinct combinations of this activation ( Fig. 8 b ) . Similar results were obtained using IL-12, IL-18, or both without anti-NKG2D mAb (unpublished data). This demonstrates that p110 ␦ D910A/D910A NK cells are fully capable of responding through their cytokine receptors.
of the chemokines MIP1-␣ , MIP1-␤ , and RANTES from p110 ␦ D910A/D910A NK cells was also significantly reduced ( Fig. 6 b ) . Similar reductions in the cytokines and chemokines were observed in the BM-derived p110 ␦ D910A/D910A NK cells (Fig. S7 , available at http://www.jem.org/cgi/ content/full/jem.20072327/DC1). This substantial reduction could be caused by the inability of the p110 ␦ D910A/D910A NK cells to produce cytokines or simply by a defect in cytokine secretion. To distinguish between these two possibilities, IFN-␥ production in response to anti-NKG2D mAb was measured by intracellular staining. The percentage of IFN-␥ -positive cells among gated NK1.1 + populations in p110 ␦ D910A/D910A NK cells was signifi cantly lower compared with WT/WT NK cells (P = 0.017; Fig. 7 a ) Inactivation of p110 ␦ reduced the number and functions of NK cells, particularly, the Ly49C/I subsets. Therefore, to determine the cytokine defects in individual Ly49 subsets, we analyzed the levels of intracellular IFN-␥ in each one of them. All of the subsets from p110 ␦ D910A/D910A mice generated a signifi cantly less amount of intracellular IFN-␥ (P < 0.007; Fig. 7 b ) , p110 ␦ D910A/D910A NK cells in a dose-dependent manner. However, the inhibition on p110 ␦ D910A/D910A NK cells was significantly less than that on WT/WT NK cells ( Fig. 10 b ) . Blocking the function of p38 with its inhibitor, SB202190, had no signifi cant eff ect on NKG2D-mediated lysis of the same target NK-mediated cytokine production requires p110 ␦ during antiinfl uenza response Infl uenza virus primarily infects lung epithelial cells that can lead to lung pathogenesis. Hence, in this study, we used mouse lung epithelial cells (LA4) to characterize the role of p110 ␦ in NK cytotoxicity and cytokine generation during influenza virus infection. We detected the cell-surface expression of viral HA on LA4 cells ( Fig. 9 a ) after they were infected with PR8, a mouse-adapted human infl uenza virus. A previous study showed that HA functions as a viral ligand for NCR1, and its interaction with NCR1 can initiate NK cytolysis against PR8-infected 1106mel cells ( 21 ) . To determine the role of p110 ␦ in regulating the NCR1-mediated NK cell recognition of PR8-infected LA4 cells, we first compared the WT and p110 ␦ D910A/D910A NK cytotoxicity. Co-incubation of WT/WT NK cells with uninfected LA4 cells led to a basal level of cytotoxicity. PR8 infection of LA4 cells moderately increased the cytotoxic potentials of WT/ WT NK cells. However, such an increase in the cytotoxicity was not observed with p110 ␦ D910A/D910A NK cells ( Fig. 9 b ) . Further, direct observations of the lysis of PR8-infected LA4 in NK/LA4 co-cultures ( Fig. 9 c ) validated the reduced ability of the p110 ␦ D910A/D910A NK cells to mediate killing of virally infected cells. Because NK cells can generate infl ammatory cytokines during viral infection ( 46 ), we quantifi ed these soluble mediators in the supernatants of PR8-infected LA4/NK co-cultures. Results presented in Fig. 9 d demonstrate that although the WT/WT NK cells could produce ample levels of IFN-␥ and GM-CSF, p110 ␦ D910A/D910A NK cells generated signifi cantly lower levels of these two cytokines. Collectively, these results for the fi rst time demonstrate that p110 ␦ plays a crucial role in the NK cell -mediated cytokine generation during antiinfl uenza viral responses. JNK1/2 regulates cytokine generation downstream of p110 ␦ What are the downstream targets of p110 ␦ that regulate the cytotoxicity and cytokine gene transcriptions? Earlier studies have shown that activation of mitogen-activated protein kinases (MAPKs) are required for cytotoxic granule release and cytokine generation in mouse and human NK cells ( 47 -50 ) . Also, the proposed involvement of p38 and JNK1/2 in regulating NK cell eff ector functions is contentious ( 49, 50 ) . To identify the target molecules downstream of p110 ␦ , NK cells were activated with plate-bound NKG2D mAb, and their lysates were analyzed for the activation status of multiple MAPKs. Phosphorylation levels of extracellular signal-regulated kinase (ERK) 1/2 were comparable between the activated WT/WT and p110 ␦ D910A/D910A NK cells. p38 phosphorylation is slightly but consistently reduced in p110 ␦ D910A/D910A NK cells ( Fig. 10 a ) . However, the level of JNK1/2 phosphorylation was significantly reduced in p110 ␦ D910A/D910A NK cells ( Fig. 10 a ) . These results indicate that JNK1/2 are major target molecules downstream of p110 ␦ in NK cells. We confi rmed the role of JNK1/2 using a specifi c pharmacological inhibitor of JNK activation, SP600125. Use of this inhibitor signifi cantly reduced NKG2D-mediated lysis of EL4 H60 target cells by both WT/WT and erate cytokines and chemokines in a dose-dependent manner. Conversely, p38 inhibitor only weakly blocked the cytokine generation, further confi rming the crucial role of JNK1/2 in cytokine gene transcription. To avoid the nonspecifi c inhibition on other kinases, we tested, selected, and used two optimal concentrations of JNK1/2 and p38 inhibitors ( 51 ) . Further, cells treated under these concentrations were tested for their viability using Annexin V and 7-AAD staining, which excluded cell death as the reason for our observations (unpublished data). Based on these results, we conclude that impairment in the JNK1/2 activation is a probable cause for the defect in cytotoxicity and cytokine generation in p110 ␦ D910A/D910A NK cells.
DISCUSSION
In this study, we present genetic evidence that unmasks the critical functions of PI3K-p110 ␦ in NK cells. The important role of PI3K in T and B cell development and function has been extensively characterized ( 28, 29, 32 ) . Using p110 ␦ D910A/D910A mice, we demonstrate that p110 ␦ plays a crucial role in NK cell terminal maturation and cytokine/chemokine generation.
In recent years, multiple p85 and p110 gene KO mice have been generated ( 28, 29, 33, 52, 53 ) . Interestingly, in these KO mice, altering the expression of one PI3K subunit has aff ected the expression of others. Cells from p85 ␣ KO mice contained increased levels of p85 ␤ and decreased expression of p110 ␣ , p110 ␤ , and p110 ␦ ( 28, 29 ). In contrast, the levels of p85 ␣ expression were augmented in p110 ␣ KO mice ( 33 ) . Some of these mice have been recently used to characterize the development and functions of NK cells. Tassi et al. shows a signifi cant reduction of p85 ␣ subunit in NK cells derived from p110 ␦ KO mice ( 54 ) . Also, NK cells from these mice have increased expression of p110 ␤ and p110 ␥ subunits, although the p110 ␣ expression level was not changed. Recently, another independently generated p110 ␦ KO mice were used by Kim et al. in a NK cell study ( 55 ) , and an earlier characterization of these mice showed decreased expression of p85 ␣ , p55 ␣ , and p50 ␣ subunits in B cells ( 52 ) . Therefore, in this study, we used mice with a point mutation that completely inactivated the catalytic function of p110 ␦ subunit without altering the normal expression levels of p110 ␦ protein ( 32 ) . More importantly, this strategy did not result in any compensatory change in the expression levels of total p85, p110 ␣ , and p110 ␤ subunits in thymocytes ( 32 ) . In the present study, we show that both BM-and spleen-derived NK cells from p110 ␦ D910A/D910A mice did not have any alteration in the levels of either p110 ␦ or other p110 subunits. Further, there were no changes in the levels of total p85 or p85 ␣ subunits. These results are in line with our earlier observations ( 32 ) . However, one of the major concerns in introducing a single amino acid change in p110 ␦ protein is its possible dominant negative eff ect. Our earlier fi ndings demonstrated a diff erential sensitivity of distinct receptor systems after p110 ␦ inactivation in p110 ␦ D910A/D910A mice ( 56 ) . For example, PI3K signaling via c-kit and Fc RI receptors was almost fully abolished in p110 ␦ D910A/D910A mast cells; this is in contrast to PI3K (Akt/protein kinase B) signaling induced by IL-3, which was cells ( Fig. 10 b ) . To determine their role in cytokine generation, we blocked JNK1/2 and p38 and assayed the ability of NK cells to respond to anti-NKG2D mAb -mediated stimulation. Fig. 10 c shows that inhibiting JNK function abolished the ability of both WT/WT and p110 ␦ D910A/D910A NK cells to gen- activity of p110 ␦ is dispensable for the early NK cell development. In addition, earlier studies from us and others showed that a lack of phospholipase C ␥ 2 did not alter the numbers of CD122 + NKPs ( 59 -61 ) . Thus, it appears that neither p110 ␦ nor phospholipase C ␥ 2 are needed for the commitment of early progenitors into NK lineage. In the second developmental stage, NKPs acquire NK1.1, NKG2D, and CD94/NKG2A/ C/E in a sequential developmental process ( 34 ) . The start of the expression of integrins such as CD49b and CD51 is also part of this second stage ( 34, 58 ) . Normal expressions of these markers by p110 ␦ D910A/D910A NK cells in the BM and spleen demonstrate that NK maturation is not hindered at this stage.
Mature mouse NK cells are defi ned by the expression of one or more Ly49 receptors. Terminal maturation of NK cells is initiated by a decrease in the expression of CD51, active proliferation, and a concomitant increase in the levels of both CD11b and CD43 ( 34 ) . At this stage, the " immature " NKPs start acquiring diff erent Ly49s ( 58 ) . Analyses of Ly49 expression only partially blocked ( 56 ) . The remaining PI3K signaling downstream of the IL-3 receptor could be fully blocked by broad-spectrum PI3K inhibitors ( 56 ) , indicating that kinasedead p110 ␦ does not exert a dominant-negative function. Thus, a knock-in mouse with a point mutation in p110 ␦ that abolishes its kinase function but not its protein expression provides an exclusive system to delineate the precise functions of PI3K in NK cells.
Using p110 ␦ D910A/D910A mice, we first determined the development and maturation of NK cells. Common lymphoid progenitors that give rise to T, B, and NK cells have been found in the BM ( 57 ) . Committed NK precursors (NKPs), which exclusively mature into NK cells, have been identifi ed in the fetal thymus and in adult BM ( 58 ) . This earliest developmental stage of NKPs is defi ned by the expression of CD122. Thus, the expression of CD122 uniquely marks the committed NKPs ( 35 ) . The expression of CD122 in p110 ␦ D910A/D910A NK cells is comparable to that of WT, indicating that the catalytic observed variations in the results. Recent studies indicated that the mature CD11b + NK cells can be further subdivided into CD27 High and CD27 Low ( 39 ) . This study demonstrated that CD27 High NK cells were superior in their ability to lyse target cells and generated considerably higher amounts of IFN-␥ compared with those of CD27 Low cells.
Reduction in the Ly49C and Ly49I NK subsets in p110 ␦ D910A/D910A mice needs further evaluation. Gene deletion of another lipid phosphatase, PTEN , whose major substrate is phosphatidylinositol (3,4,5)-triphosphate, leads to an increased Ly49C and Ly49I expression in NKT cells ( 62 ) . Interestingly, this abnormal increase of Ly49C or Ly49I in NKT cells from PTEN KO mice was reversed by backcrossing the PTEN -defi cient mice with p110 ␦ D910A/D910A mice ( 62 ) . Collectively, our on p110 ␦ D910A/D910A NK cells indicated an exclusive reduction in Ly49C and Ly49I subsets. Other NK subsets, such as Ly49A, Ly49G2, and Ly49D were normal. Recently, Tassi et al. has used p110 ␥ , p110 ␦ , or p110 ␥ / ␦ double KO mice to determine the NK cell development and function ( 54 ) . These studies showed reductions in Ly49A and Ly49C/I subsets in p110 ␥ and p110 ␥ /p110 ␦ double KO mice; however, no changes were observed in Ly49C/I NK subsets in p110 ␦ KO mice. Conversely, Kim et al., using independently generated KO mice, dem onstrated small reductions in the Ly49C/I in p110 ␥ KO mice and Ly49G2 in p110 ␦ KO mice ( 55 ) . The p110 ␦ D910A/D910A mice used in the present study and one of the two p110 ␦ KO mice are of the C57BL/6 background. This suggests that strain diff erences in mice did not account for the main of JNK1 and JNK2 needs combined stimulation through TCR and CD28 together; alone, each stimulus resulted in little or no eff ect ( 70 ) . Our data indicate that JNK1/2 are critical downstream eff ectors of P110 ␦ , and that they could regulate cytokine gene transcription and cytotoxic granule release. These fi ndings are in line with the recent observations in an NKG2D-expressing human NKL cell line, where inhibition of JNK activity resulted in the impaired movement of microtubule organizing center, granzyme B, and paxillin to the immune synapse ( 49 ) . Several transcription factors as substrates have been described for JNK1/2, including activator protein 1 ( 71 ) . Evidence for this is provided by the activator protein 1 -dependent cytokine gene transcription in Fc ␥ RIIIA-stimulated human NK cells ( 72 ) . In conclusion, our current observations establish a strong basis to further explore PI3K-mediated novel NK cell cytokine generation pathways.
NK cells can clear an intracellular infection either by direct killing of the infected cells or through the release of cytokines, e.g., IFN-␥ . It has been demonstrated that NK cells can recognize and kill infl uenza virus -infected cells through the interaction of NCR1 with viral HA ( 21 ) . Further, functional loss of NCR1 caused lethal infl uenza virus infection in a mouse model ( 73 ) . However, the signaling pathway governing NCR1-mediated activation has not been investigated. Infl uenza virus primarily target respiratory cells. Mouse lung epithelial cells (LA4) can be infected with PR8 and express viral HA. p110 ␦ D910A/D910A NK cells showed reduced lysis against PR8-infected cells, which indicates the involvement of p110 ␦ in NCR1-mediated cytotoxicity. Most significantly, the p110 ␦ D910A/D910A NK cells were impaired in their ability to produce IFN-␥ and GM-CSF upon recognition of PR8-infected LA4, confi rming the importance of p110 ␦ in antiviral immunity. Replication of high pathogenic infl uenza infection usually peaks within 5 d ( 74 ) . Controlling fl u infection during this short time window currently relies on antifl u drugs and vaccines, which usually are not eff ective for virulent infl uenza virus. Our results suggest an alternative approach to control emerging pandemic infl uenza infection by boosting the NK cell eff ector functions through potential drugs specifically targeted to signaling molecules.
MATERIALS AND METHODS
Mice and cell lines. Generation of PI3K-p110 ␦ D910A/D910A mice was previously described ( 30 ) . PI3K-p110 ␦ D910A/D910A mice used in the present study were backcrossed to C57BL/6 for N12/N13 generations. The mutant and C57BL/6 (WT/WT) mice were maintained in pathogen-free conditions at the Biological Resource Center (BRC) of the Medical College of Wisconsin (MCW). All of the animal protocols used were approved by the Institutional Animal Care and Use Committee, BRC, MCW. Target cells (EL4, EL4 H60 , RMA/S, and YAC-1) and their culture conditions were previously described ( 35 ) . CHO cells were cultured similarly to other target cells. MadinDarby canine kidney (MDCK) cells and a mouse lung epithelial cell line (LA4) were purchased from the American Type Culture Collection and were cultured in RPMI 1640 medium with 10% or 15% FBS, respectively.
Virus and viral infections. Mouse-adapted human infl uenza virus A/PR8 (H1N1) was obtained from T. Moran (Mount Sinai School of Medicine, New York, NY). Infl uenza virus stocks were propagated in MDCK cells, and titers were determined by a plaque-forming assay.
fi ndings in the reduction of Ly49C and Ly49I expression predict a key role for p110 ␦ in the dynamic interaction between PI3K, phosphatidylinositol (3,4,5)-triphosphate, lipid phosphatases, and inhibitory Ly49 receptors.
NK cells can kill tumor cells without prior sensitization. To study the role of p110 ␦ in lytic signaling, we used diff erent tumor cells representing self, induced-self, and missing-self. Lack of p110 ␦ moderately aff ected the antitumor responses against these target cells. This marginal impairment in cytotoxicity could be caused by the reduction in the CD27 High NK subsets in p110 ␦ D910A/D910A mice, because this subset has been demonstrated to play a dominant role in cytotoxic granule release ( 39 ) . NK cells generate infl ammatory cytokines and chemokines as part of innate immunity. Previous studies demonstrated a lack of DAP12 or Syk/ZAP70 but not DAP10, severely impairing NKG2D-mediated cytokine production ( 7, 11, 63 ) . In contrast, a signifi cant reduction in cytokine generation mediated via NKG2D and Ly49D was observed in p110 ␦ D910A/D910A NK cells. Further, similar reductions were also observed when p110 ␦ D910A/D910A NK cells were activated via the NK1.1 receptor that uses FcR ␥ to mediate its signal ( 24 ) . These results suggest that p110 ␦ plays a pivotal role in the cytokine generation by NK cells. Earlier studies have demonstrated that CD-27 High CD11b High NK cells generated IFN-␥ in response to NKG2D-mediated stimuli ( 39 ) . Thus, a signifi cant decline in the CD27 High NK cells in p110 ␦ D910A/D910A mice provides additional cellular explanations for the reduction in cytokine generation. The proinfl ammatory cytokines IL-12 and IL-18, derived from monocytes, can induce IFN-␥ generation in NK cells ( 64 ) . In combinations, IL-12 and IL-18 can mediate signaling events that are distinct from those of YINM-or ITAMcontaining receptor-mediated activations. Stimulation with IL-12 and IL-18, along with a suboptimal concentration of anti-NKG2D mAb, resulted in comparable levels of IFN-␥ , GM-CSF, MIP-1 ␣ , MIP-1 ␤ , and RANTES between WT/ WT and p110 ␦ D910A/D910A NK cells. Compared with p110 ␦ KO NK cells ( 55 ), we did not observe any increased production of IFN-␥ upon IL-12 and IL-18 stimulation. We conclude that ITAM-independent pathways are fully operational in p110 ␦ D910A/D910A NK cells. An explanation for this observation comes from the comparable levels of p38 phosphorylation between WT/WT and p110 ␦ D910A/D910A NK cells, which is crucial for the generation of cytokines downstream of IL-12/ IL-18 receptors ( 65, 66 ) .
MAPKs are potential downstream targets for multiple activation receptors, including NKG2D ( 67 ) . MAPKs are serine-threonine kinases with a T-X-Y motif in their cytoplasmic domain, and they regulate multiple immune cell eff ector functions ( 68 ) . The MAPK family includes ERK1/2, JNK1/2, and p38. The regulatory roles of these MAPKs in NK functions are emerging ( 47 -50, 67, 69 ) . ERK1/2 can be activated by multiple mitogenic stimuli; however, JNK1/2 and p38 are activated by stress-inducing agents or proinfl ammatory cytokines. Earlier studies using T cells have provided evidence for the role of PI3K in JNK activation ( 70 ) . In T cells, full activation of the MAPKs that phosphorylate the Jun activation do-gels and transferred to polyvinylidene fl uoride membranes. The blot was probed with the mAbs indicated in the fi gures. Anti -rabbit PI3K-p110 ␣ , p110 ␤ , p110 ␥ , and p110 ␦ , and anti -mouse PI3K-p85 ␣ mAbs were purchased from Santa Cruz Biotechnology, Inc. Pan -anti -PI3K-p85 mAb was obtained from Millipore, and anti -␤ -actin mAb was from Boehringer Mannheim. After incubation with either horseradish peroxidase -conjugated anti -rabbit or anti -mouse mAbs (Santa Cruz Biotechnology, Inc.), membranes were washed and signals were detected using an enhanced chemiluminescence kit (GE Healthcare).
MAPK activation. Cultured NK cells were serum starved for 2 h in PBS and stimulated with plate-bound anti-NKG2D mAb for the time indicated in the fi gure. Cells were lysed directly in the 96-well plate by the addition of 1 × RIPA buff er (Boston BioProducts) containing protease inhibitors and phosphatase inhibitor cocktails (EMD). Lysates were analyzed for phospho-p38 (Thr180/Tyr182), phospho-ERK1/2 (Thr202/Tyr204), phospho-JNK1/2 (Thr183/Tyr185), respective total proteins, and ␤ -actin (Cell Signaling Technology) by Western blotting.
Cytokine and chemokine quantifi cation. Fresh or IL-2 -cultured, Fcblocked NK cells were activated with titrated concentrations of plate-bound anti-NKG2D (A10), anti-Ly49D (4E5), and anti-NK1.1 (PK136) mAbs. Where indicated in the fi gures, NK cells were activated with 2.5 ng/ml IL-12 and 2.5 ng/ml IL-18, or both, in the presence ( Fig. 9 ) or absence (not depicted) of anti-NKG2D mAb (A10). IFN-␥ , GM-CSF, MIP-1 ␣ , MIP-1 ␤ , and RANTES were quantifi ed using Multiplex kit (Bio-Rad Laboratories). Intracellular cytokines were quantifi ed using established methodologies ( 75 ) . In brief, NK cells were activated with 10 μ g/ml of plate-bound anti-NKG2D (A10) mAb for 12 h in the presence of Brefeldin A for the last 4 h of activation. Activated NK cells were Fc-blocked; stained for NK1.1 alone or in combination with anti-Ly49A, -Ly49D, -Ly49C/I, -Ly49I, or -Ly49G2 mAbs; fi xed; permeabilized; and quantifi ed for intracellular IFN-␥ using FITC-(eBioscience) or PE-(BD Biosciences) conjugated anti -IFN-␥ mAbs through fl ow cytometry. For IFN-␥ encoding mRNA quantifi cation, NK cells were activated for 6 h and harvested for RNA extraction using the RNeasy Mini Kit (QIAGEN). IFN-␥ real-time PCR was performed by using a previously published SYBR green protocol with a thermal cycler (model 7900HT; Applied Biosystems) ( 76 ) . The transcript in each sample was assayed in triplicate, and the mean cycle threshold was used to calculate the x -fold change and control changes for each gene. Three housekeeping genes were used for global normalization in each experiment ( Actin , Rps11 , and Tubulin ). Data validity by modeling of reaction effi ciencies and analysis of measurement precision was determined as described previously ( 76 ) . Primer sequences for IFN-␥ were 5 Ј -GACTGTGATTGCGGGGTTGT-3 Ј (sense) and 5 Ј -GGCCCGGAGTGTAGACATCT-3 Ј (antisense).
Drug inhibition assay. p38 and JNK specifi c inhibitors SB 202190 and SP600125 (Sigma-Aldrich) were dissolved in DMSO and used in a cytotoxicity assay with 51 Cr-labeled EL4 H60 or a cytokine stimulation assay using plate-bound anti-NKG2D mAb. Starting concentrations for inhibitors were 20 μ M, based on the kinase activity curve ( 51 ) . In brief, cultured NK cells were harvested and seeded into 96-well plates at 10 5 cells for the cytotoxicity inhibition assay. Before incubation with target cells, NK cells were treated with SB 202190 or SP600125 for 1 h at 37 ° C, washed, and combined with target cells in a 4-h cytotoxicity assay. For cytokine stimulation, 2 × 10 5 NK cells/well were seeded directly into 96-well plates that were precoated with anti-NKG2D mAb, followed by the addition of SB 202190 and SP600125 inhibitors. Plates were incubated for 1 h at 37 ° C, washed, and added with 200 μ l RPMI 1640 with 10% FBS per well in an 18-h stimulation assay. Potential apoptosis caused by both inhibitors at each concentration was tested by 7-AAD and Annexin V staining.
Statistics.
Statistical analysis was performed with the two-tailed, unpaired Student ' s t test using Microsoft Excel 2003 software to compare the diff erences between WT/WT and PI3K-p110 ␦ D910A/D910A mice. P ≤ 0.05 was considered signifi cant. NK cell preparation. NK cells were purifi ed as previously described ( 35 ) . In brief, single-cell suspensions from spleen and BM were passed through nylon wool columns to deplete adherent populations consisting of B cells and macrophages. Nylon wool -nonadherent cells were cultured with 1,000 U/ml of IL-2 (NCI BRB Preclinical Repository). Purity of the NK cultures was checked, and preparations with > 90% NK1.1 + cells were used. Alternatively, for ex vivo assays, NK cells were purifi ed with DX5 mAb (eBioscience) by magnetic sorting according to manufacture ' s protocol. Purify of NK cells was usually ‫ف‬ 80%.
Co-culture assays. 2.5 × 10 5 LA4 cells per well were seeded in 24-well tissue culture plates overnight. Cells were washed twice and inoculated with PR8 at a multiplicity of infection (MOI) of 0.05. After a 1-h incubation at 37 ° C, the inoculum was removed and LA4 cells were washed twice, followed by the addition of IL-2 -activated splenic NK cells at the ratios indicated in the fi gures. Supernatants were collected at the times indicated in the fi gures for cytokine quantifi cation.
Flow cytometry. Cell preparations were stained with fl uorescent-labeled mAbs, as previously described ( 75 ) . mAbs for NK1.1 (PK136), CD3 (145-2C11), NKG2D (A10), NKG2A (16a11), CD43 (1B11), CD49b (DX5), CD51 (RMV-7), CD69 (H1.2F3), CD122 (5H4), CD11b (M1/70), CD27 (LG.7F9), and Ly49I (YLI-90) were obtained from eBioscience. mAbs for CD244 (2B4), Ly49A (A1), Ly49D (4E5), Ly49C/I (5E6), and Ly49G2 (4D11) were obtained from BD Biosciences. mAbs for mouse H-2K b and H-2D b were obtained from Invitrogen. Antibody for infl uenza HA (IVC102) was obtained from GeneTex, Inc. A standard fl ow cytometry analysis was performed using an LSR II with FACSDiva software (Becton Dickinson). IL-2 -activated splenic NK cells derived from p110 ␦ D910A/D910A mice were also stained with Ly49C/I (5E6) and Ly49G2 (4D11) mAbs and subjected to cell sorting using a FACSAria (Becton Dickinson). Cytotoxicity of sorted NK subsets was tested against EL4 H60 (see the following section).
Cytotoxicity assays. NK-mediated cytotoxicity was quantifi ed using 51 Crlabeled target cells, including EL4, EL4 H60 , RMA/S, YAC-1, CHO, and PR8-infected and noninfected LA4 cells at varied eff ector/target ratios. Anti-NKG2D mAb C7 (eBioscience) were used at the concentrations indicated in the fi gures to block the recognition of H60 on EL4 H60 through the NKG2D receptor. The percentage of specifi c lysis was calculated using amounts of absolute, spontaneous, and experimental 51 Cr release from target cells. For the in vivo tumor clearance assay, RMA and RMA/S cells were labeled with 0.1 μ M CFSE and 0.2 μ M SNAF (Invitrogen), respectively, for 10 min and were quenched with 10% FBS 1640 medium. Cells were mixed at a concentration of 10 × 10 6 cells/ml of each in PBS, and 400 μ l was injected intraperitoneally into each mouse. Peritoneal exudate was collected 6 h later, and the fl uorescence of single-cell suspensions was analyzed by fl ow cytometry. The ratio of RMA/S to RMA cells was calculated. NK cells in the cell suspensions were analyzed by staining with anti-CD3 and anti-NK1.1 mAbs. A dye swap was also performed.
NK cell proliferation. Splenic NK cells were cultured for 6 d, harvested, seeded into a 6-well plate (2 × 10 6 cells/well), and incubated for 2 h. BrdU was then added to a fi nal concentration of 10 μ M, and cells were further incubated for 4 h, after which cells were stained with anti-CD3, -NK1.1, -Ly49A, -Ly49C/I, and -Ly49G2 mAbs for 30 min on ice, washed, and fi xed with 1% paraformaldehyde -0.01% Tween-20 in PBS at 4 ° C for 20 min. Cells were washed and resuspended in permeabilization buff er containing 50 Kunitz DNase I/ml and incubated for 30 min at 37 ° C. After the wash, cells were finally stained with anti -BrdU-FITC (BD Biosciences). For apoptosis analysis, 6-d IL-2 -activated NK cells were stained with FITC-conjugated mAbs for Ly49A, Ly49D, Ly49C/I, and Ly49G2; washed; and stained with 7-AAD and Annexin V -PE (BD Biosciences), according to manufacturer ' s protocol.
Western blotting. Immunoblots of PI3K-p110 isoforms in NK cells were performed. In brief, 10 6 NK cell lysates were resolved using 10% SDS-PAGE Online supplemental material. Fig. S1 shows expression levels of early developmental markers in fresh splenic NK cells. Fig. S2 shows normal expression levels of developmental and activation markers in IL-2 -activated NK cells. Fig. S3 shows that catalytic inactivation of PI3K-p110 ␦ does not aff ect the normal expression of MHC class I molecules. Fig. S4 shows that the reduced Ly49C/I NK subset is not caused by cell death in PI3K-p110 ␦ D910A/D910A mice. Fig. S5 shows that the cytotoxicity of NK cells directed toward EL4 H60 is predominantly mediated through the NKG2D receptor. Fig. S6 shows that NK cells from PI3K-p110 ␦ D910A/D910A mice have decreased abilities to clear tumor cells in vivo. Fig. S7 shows that IL-2 -activated BM-derived NK cells from PI3K-p110 ␦ D910A/D910A mice have a reduced ability to generate cytokines and chemokines. Online supplemental material is available at http://www .jem.org/cgi/content/full/jem.20072327/DC1.
